期刊文献+

终末期冠心病的干细胞移植治疗 被引量:2

Stem cell transplantation therapy in terminal coronary heart disease
下载PDF
导出
作者 葛均波
出处 《老年医学与保健》 CAS 2003年第4期201-205,共5页 Geriatrics & Health Care
基金 上海市科委基金资助课题(编号03XD14010)
  • 相关文献

参考文献19

  • 1[1]Pfeifer MA, Braunwald E. Ventricular remodeling after myocardial infarction:experimental observations and clinical implications. Circulation,1990,81:1161~ 1172.
  • 2[2]Li RK, Mickle DA, Weisel RD,et al. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res,1996,78:283~ 288.
  • 3[3]Charles EM, Robert WW, Stephen MS. Skeletal Myoblast Transplantation for Repair of Myocardial Necrosis.J Clin Invest,1996,98(11):2512~ 2523.
  • 4[4]Donald O, Jan K, Stefano C, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001,410:701~ 705.
  • 5[5]Mohit J, Harout D, Daniel AB,et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction.Circulation,2001,103:1920~ 1927.
  • 6[6]Chiu RC,Zibaitis A,Kao RL.Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation.Ann Thorac Surg,1995,60:12~ 18.
  • 7[7]Rajnoch C, Chachques JC, Berrebi A,et al.Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg,2001,121:871~ 878.
  • 8[8]Jian YM, Matthew FS, Yinke Y, et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg, 2002, 74:1568~ 1575.
  • 9[9]Menasche B, Hagege AA, Scorsin M. Myoblast transplantation for heart failure. Lancet,2001,357;279~ 280.
  • 10[10]Kehat I, Kenyagin- Karsenti D, Snir M. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 2001,108:407~ 414.

同被引文献23

  • 1杨焱,崔晓迎.急性心肌梗死介入治疗研究进展[J].内蒙古医学院学报,2006,28(S1):101-104. 被引量:1
  • 2Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure.N Engl J Med,2001,344:1651-1658.
  • 3Pitt B,Sannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.N Engl J Med,1999,341:709-717.
  • 4Rose EA,Gelijns AC,Moskowitz AJ,et al.Long-term use of a left ventricular assist device for end-stage heart failure.N Engl J Med,2001,345:1435-1443.
  • 5Braunschweig F,Linde C.Continuous hemodynamic monitoring in heart failure.J Cardiovasc Electrophysiol,2002,13(Suppl):S68-S72.
  • 6Braumschweig F,Linde C,Eriksson MJ,et al.Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.Eur Heart J,2002,23:59-69.
  • 7Podrid PJ,Fogel RI,Tordjman-Fuchs T.Arrhythmia in patients with cardiomyopathy and congestive heart failure.In:Hosenpud JD,Greenberg BH,eds.Congestive heart failure.New York:Springer-Verlag,1994.653-654.
  • 8Goldman S,Johnson G,Cohn JN,et al.Mechanism of death in heart failure:the vasodilator-heart failure trials.Circulation,1993,87 (Suppl):Ⅵ24-Ⅵ31.
  • 9Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.N Engl J Med,2002,346:877-883.
  • 10Saman N,William HM,Miles JS,et al.Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure.Am Heart J,2005,150:955-960.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部